Troglitazone-Associated Hepatic Failure
- Brent A. Neuschwander-Tetri, MD;
- William L. Isley, MD; and
- Julie C. Oki, PharmD
- St. Louis University School of Medicine; St. Louis, MO 63110 (Neuschwander-Tetri) St. Lukes Hospital; Kansas City, MO 64111 (Isley) University of Missouri-Kansas City School of Medicine; Kansas City, MO 64108 (Oki)
The Editors welcome submissions for possible publication in the Letters section. Authors of letters should:
•Include no more than 300 words of text, three authors, and five references
•Type with double-spacing
•Send three copies of the letter, an authors' form signed by all authors, and a cover letter describing any conflicts of interest related to the contents of the letter.
Letters commenting on an Annals article will be considered if they are received within 6 weeks of the time the article was published. Only some of the letters received can be published. Published letters are edited and may be shortened; tables and figures are included only selectively. Authors will be notified that the letter has been received. If the letter is selected for publication, …
RSS Feeds









